Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Myrup

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|October 21, 1991
[Deep-vein thrombophlebitis and pulmonary embolism as a sign of malignant disease]B Myrup
Journal of Internal Medicine|July 1, 1995
Primary haemostasis in thyroid diseaseB Myrup, C Bregengård, J Faber
Archives of Internal Medicine|November 1, 1992
Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatmentB Myrup, G F Jensen, P McNair
Journal of Diabetes and Its Complications|April 1, 1995
Heparin, a possible therapy for diabetic complications: the effect on mesangial and myomedial cells in vivo and in vitro, especially in relation to extracellular matrixH Yokoyama, B Myrup, P Oturai, et al.
The American Journal of Clinical Nutrition|June 1, 1992
n-3 fatty acids in adipose tissue and coronary artery disease are inversely relatedK N Seidelin, B Myrup, B Fischer-Hansen
Gut|March 20, 1998
Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factorB Myrup, N H Valerius, P B Mortensen
Diabetes Research (Edinburgh, Scotland)|January 1, 1994
Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitusB Myrup, E R Mathiesen, B Rønn, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 31, 1991
Platelet aggregation and fatty acid composition of platelets in type 1 diabetes mellitusB Myrup, C Bregengaard, L R Petersen, et al.
Diabetes Care|May 1, 1996
Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathyH Yokoyama, B Myrup, P Rossing, et al.
Angiology|January 1, 1993
Decreased platelet activity without change in fibrinolytic activity after low dosages of fish oilK Winther, B Myrup, G Hølmer, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|October 21, 1991
[Deep-vein thrombophlebitis and pulmonary embolism as a sign of malignant disease]B Myrup
Journal of Internal Medicine|July 1, 1995
Primary haemostasis in thyroid diseaseB Myrup, C Bregengård, J Faber
Archives of Internal Medicine|November 1, 1992
Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatmentB Myrup, G F Jensen, P McNair
Journal of Diabetes and Its Complications|April 1, 1995
Heparin, a possible therapy for diabetic complications: the effect on mesangial and myomedial cells in vivo and in vitro, especially in relation to extracellular matrixH Yokoyama, B Myrup, P Oturai, et al.
The American Journal of Clinical Nutrition|June 1, 1992
n-3 fatty acids in adipose tissue and coronary artery disease are inversely relatedK N Seidelin, B Myrup, B Fischer-Hansen
Gut|March 20, 1998
Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factorB Myrup, N H Valerius, P B Mortensen
Diabetes Research (Edinburgh, Scotland)|January 1, 1994
Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitusB Myrup, E R Mathiesen, B Rønn, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 31, 1991
Platelet aggregation and fatty acid composition of platelets in type 1 diabetes mellitusB Myrup, C Bregengaard, L R Petersen, et al.
Diabetes Care|May 1, 1996
Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathyH Yokoyama, B Myrup, P Rossing, et al.
Angiology|January 1, 1993
Decreased platelet activity without change in fibrinolytic activity after low dosages of fish oilK Winther, B Myrup, G Hølmer, et al.
Pageof 2